Focus on anastrozole and breast cancerMOKBEL, K.Current medical research and opinion. 2003, Vol 19, Num 8, pp 683-688, issn 0300-7995, 6 p.Article

Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate. DiscussionAAPRO, Matti S; FORBES, John F; HENDERSON et al.Breast cancer research and treatment. 2003, Vol 80, pp S3-S18, issn 0167-6806, 15 p., SUP1Conference Paper

Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitorsYAHIAOUI, Samir; POUGET, Christelle; FAGNERE, Catherine et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 20, pp 5215-5218, issn 0960-894X, 4 p.Article

Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography-⁶³Ni electron capture detectionBOCK, M. J. H; BARA, I; LEDONNE, N et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 700, Num 1-2, pp 131-138, issn 1387-2273Article

Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole ― of clinical importance?GEISLER, J.British journal of cancer. 2011, Vol 104, Num 7, pp 1059-1066, issn 0007-0920, 8 p.Article

Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitorsBHATNAGAR, A. S; BRODIE, A. M. H; LONG, B. J et al.Journal of steroid biochemistry and molecular biology. 2001, Vol 76, Num 1-5, pp 199-202, issn 0960-0760Conference Paper

Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertilityTURNER, K. J; MORLEY, M; ATANASSOVA, N et al.Journal of endocrinology. 2000, Vol 164, Num 2, pp 225-238, issn 0022-0795Article

Anastrozole : A selective aromatase inhibitor for the treatment of breast cancerHIGA, G. M; ALKHOURI, N.American journal of health-system pharmacy. 1998, Vol 55, Num 5, pp 445-452, issn 1079-2082Article

Aromatase inhibitors and breast cancerMILLER, W. R.Cancer treatment reviews. 1997, Vol 23, Num 3, pp 171-187, issn 0305-7372Article

Overview of Chemotherapy and Nine Commonly Prescribed Chemotherapeutic MedicationsSMITH, Tara L; CARTER, Chenita W.The Journal of pharmacy technology. 2010, Vol 26, Num 6, pp 335-339, issn 8755-1225, 5 p.Article

Pharmacology of inhibitors of estrogen biosynthesisBHATNAGAR, A. S; MILLER, W. R.Handbook of experimental pharmacology. 1999, Vol 135, pp 223-230, issn 0171-2004, 2Article

Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: A prospective, randomized, phase III studyMILLA-SANTOS, Alfredo; MILLA, Lidon; PORTELLA, Jordi et al.American journal of clinical oncology. 2003, Vol 26, Num 3, pp 317-322, issn 0277-3732, 6 p.Article

Lipid profiles within the SABRE trial of anastrozole with and without risedronatePOZNAK, Catherine Van; MAKRIS, Andreas; CLACK, Glen et al.Breast cancer research and treatment. 2012, Vol 134, Num 3, pp 1141-1147, issn 0167-6806, 7 p.Article

Overview of adjuvant trials of aromatase inhibitors in early breast cancerINGLE, James N.Steroids. 2011, Vol 76, Num 8, pp 765-767, issn 0039-128X, 3 p.Conference Paper

Impact of aromatase inhibitors on adhesion formation in a rat modelKAYA, Umit; OKTEM, Mesut; ZEYNELOGLU, Hulusi B et al.Fertility and sterility. 2007, Vol 87, Num 4, pp 934-939, issn 0015-0282, 6 p.Article

Effects of adjuvant aromatase inhibitor therapy on lipid profilesMONNIER, Alain.Expert review of anticancer therapy. 2006, Vol 6, Num 11, pp 1653-1662, issn 1473-7140, 10 p.Article

Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal womenAGORASTOS, Theodoros; VAITSI, Violeta; PANTAZIS, Konstantinos et al.European journal of obstetrics, gynecology, and reproductive biology. 2005, Vol 118, Num 2, pp 239-240, issn 0301-2115, 2 p.Article

Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifenKIJIMA, Ikuko; ITOH, Toru; SHIUAN CHEN et al.Journal of steroid biochemistry and molecular biology. 2005, Vol 97, Num 4, pp 360-368, issn 0960-0760, 9 p.Article

Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis : a pilot studyHEFLER, Lukas A; GRIMM, Christoph; VAN TROTSENBURG, Michael et al.Fertility and sterility. 2005, Vol 84, Num 4, pp 1033-1036, issn 0015-0282, 4 p.Article

Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian womenDOWSETT, M; DONALDSON, K; TSUBOI, M et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 1, pp 35-39, issn 0344-5704Article

Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancerROBERTSON, J. F. R; HOWELL, A; BUZDAR, A et al.Breast cancer research and treatment. 1999, Vol 58, Num 2, pp 157-162, issn 0167-6806Article

A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotropinsSIPE, Christopher S; DAVIS, William A; MAIFELD, Michelle et al.Fertility and sterility. 2006, Vol 86, Num 6, pp 1676-1681, issn 0015-0282, 6 p.Article

Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal womenTHÜRLIMANN, B; ROBERTSON, J. F. R; NABHOLTZ, J. M et al.European journal of cancer (1990). 2003, Vol 39, Num 16, pp 2310-2317, issn 0959-8049, 8 p.Article

Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole. DiscussionCARLSON, Robert W; HENDERSON, I. Craig; FORBES et al.Breast cancer research and treatment. 2003, Vol 80, pp S19-S28, issn 0167-6806, SUP1Conference Paper

The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell linesLAN SHEN; ZIMING LI; SHENGPINGSHEN et al.Lung cancer. 2012, Vol 78, Num 3, pp 193-200, issn 0169-5002, 8 p.Article